Sumitomo Pharmaceuticals

Sumitomo Pharmaceuticals has marketed various new drugs for diseases for which there had been no effective remedies.Sumitomo Pharmaceuticals has brought to market several new drugs for diseases that had previously had no effective remedies: Sumiferon, a natural alpha interferon for the treatment of hepatitis C; Dops, a drug for Parkinson disease; Meropen, a carbapenem antibiotic;Almarl, a drug for hypertension, angina pectoris, arrhythmias, and essential tremor; and Sediel, a serotonin agonist for the treatment of anxiety.Strives to continue contributing to medical progress and to assist in maintaining and developing healthy lifestyles among today's society through the research and development of innovative and effective new drugs.

Activity:

- Manufacturing

Product / Technology type(s) covered:

- Pharmaceuticals / Therapeutics

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active: Asia , Europe , North America

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: